CGT-6297

N/A

Report date: 2026/03/28 20:00:32
NME

Base Information

Drug NameCGT-6297
Drug Alias NameCGT6297CGT-6297
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursHR-positive breast cancerEndometrial Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHR-positive breast cancerEndometrial Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A